Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer
Cancer Gene Therapy, Published online: 28 December 2022; doi:10.1038/s41417-022-00585-9Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 28, 2022 Category: Cancer & Oncology Authors: Hyun Woo Ma Jung Min Kim Da Hye Kim I Seul Park Ji Hyung Kim Ki Cheong Park Dong Hyuk Seo Jae Hyeon Kim Xiumei Che Tae Il Kim Jae Hee Cheon Seung Won Kim Source Type: research
HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer
Cancer Gene Therapy, Published online: 27 December 2022; doi:10.1038/s41417-022-00577-9HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 27, 2022 Category: Cancer & Oncology Authors: Ahmed M. Mehdi Chenhao Zhou Gavin Turrell Euan Walpole Sandro Porceddu Ian H. Frazer Janin Chandra Source Type: research
Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis
Cancer Gene Therapy, Published online: 27 December 2022; doi:10.1038/s41417-022-00580-0Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 27, 2022 Category: Cancer & Oncology Authors: Jian You Bei Tao Lilei Peng Tangming Peng Haiping He Shan Zeng Jizhong Han Ligang Chen Xiangguo Xia Xiaobo Yang Chuanhong Zhong Source Type: research
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer
Cancer Gene Therapy, Published online: 21 December 2022; doi:10.1038/s41417-022-00579-7Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 21, 2022 Category: Cancer & Oncology Authors: Preeti Borde Nicola Cosgrove Sara Charmsaz Stephen T. Safrany Leonie Young Source Type: research
Small molecule-induced epigenomic reprogramming of APL blasts leading to antiviral-like response and c-MYC downregulation
Cancer Gene Therapy, Published online: 19 December 2022; doi:10.1038/s41417-022-00576-wSmall molecule-induced epigenomic reprogramming of APL blasts leading to antiviral-like response and c-MYC downregulation (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 19, 2022 Category: Cancer & Oncology Authors: Stefano Amatori Giuseppe Persico Francesco Cantatore Martina Rusin Mauro Formica Luca Giorgi Eleonora Macedi Francesca Casciaro Alfredo Errico Provenzano Stefano Gambardella Roberta Noberini Tiziana Bonaldi Vieri Fusi Marco Giorgio Mirco Fanelli Source Type: research
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts
Cancer Gene Therapy, Published online: 09 December 2022; doi:10.1038/s41417-022-00575-xFAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 9, 2022 Category: Cancer & Oncology Authors: Bin Li Zuo Ding Ozlem Calbay Yue Li Tao Li Lingtao Jin Shuang Huang Source Type: research
Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion
Cancer Gene Therapy, Published online: 09 December 2022; doi:10.1038/s41417-022-00570-2Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 9, 2022 Category: Cancer & Oncology Authors: Julia Harms Simona Mareike L üttgenau Christin Emming Justine Guske Katrin Weber Thomas Wagner Larissa Schowe Pavel Nedvetsky Michael P. Krahn Source Type: research
Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy
Cancer Gene Therapy, Published online: 09 December 2022; doi:10.1038/s41417-022-00569-9Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 9, 2022 Category: Cancer & Oncology Authors: Xisong Liang Zeyu Wang Ziyu Dai Hao Zhang Jian Zhang Peng Luo Zaoqu Liu Zhixiong Liu Kui Yang Quan Cheng Mingyu Zhang Source Type: research
Retraction Note: Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia
Cancer Gene Therapy, Published online: 09 December 2022; doi:10.1038/s41417-022-00573-zRetraction Note: Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 9, 2022 Category: Cancer & Oncology Authors: X. Zhu H. Zhao Z. Lin G. Zhang Source Type: research
miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
Cancer Gene Therapy, Published online: 09 December 2022; doi:10.1038/s41417-022-00574-ymiR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 9, 2022 Category: Cancer & Oncology Authors: Zhijiao Song Caihe Liao Liqun Yao Xuexiang Xu Xuezhen Shen Siqi Tian Shuo Wang Feng Xing Source Type: research
STMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling
Cancer Gene Therapy, Published online: 02 December 2022; doi:10.1038/s41417-022-00568-wSTMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 2, 2022 Category: Cancer & Oncology Authors: Mingrui Shao Li Wang Qi Zhang Tianlong Wang Shiyang Wang Source Type: research
Single-cell discovery of the scene and potential immunotherapeutic target in hypopharyngeal tumor environment
Cancer Gene Therapy, Published online: 02 December 2022; doi:10.1038/s41417-022-00567-xSingle-cell discovery of the scene and potential immunotherapeutic target in hypopharyngeal tumor environment (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 2, 2022 Category: Cancer & Oncology Authors: Chen Lin Yanguo Li Yidian Chu Yaqin Lu Zhengyu Wei Hongxia Deng Shanshan Gu Qi Ding Zhisen Shen Qi Liao Source Type: research
A comprehensive understanding of hnRNP A1 role in cancer: new perspectives on binding with noncoding RNA
Cancer Gene Therapy, Published online: 02 December 2022; doi:10.1038/s41417-022-00571-1A comprehensive understanding of hnRNP A1 role in cancer: new perspectives on binding with noncoding RNA (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 2, 2022 Category: Cancer & Oncology Authors: Luisa Siculella Laura Giannotti Benedetta Di Chiara Stanca Francesco Spedicato Matteo Calcagnile Stefano Quarta Marika Massaro Fabrizio Damiano Source Type: research
GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin
Cancer Gene Therapy, Published online: 02 December 2022; doi:10.1038/s41417-022-00566-yGAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 2, 2022 Category: Cancer & Oncology Authors: Haiyang Wang Ding Wang Yongfeng Shen Chenglong Sun Qiang Hu Li Jiang Quan Du Source Type: research
Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion
Cancer Gene Therapy, Published online: 02 December 2022; doi:10.1038/s41417-022-00564-0Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 2, 2022 Category: Cancer & Oncology Authors: Ana Carolina Caballero Laura Escrib à-Garcia Paula Pujol-Fern ández Eva Escudero-L ópez Cristina Ujald ón-Miró Rosanna Montserrat-Torres Jorge Sierra Carmen Alvarez-Fern ández Javier Briones Source Type: research
